Table 2 Cancer related characteristics
Characteristic | n (%) |
|---|---|
Type of cancer | |
Solid tumour | 1116 (88.8%) |
Brain tumour | 286 (22.8%) |
Gastrointestinal cancer | 282 (22.4%) |
Head and neck cancer | 189 (15.0%) |
Lung cancer | 129 (10.3%) |
Urogenital cancer | 83 (6.6%) |
Breast cancer | 58 (4.6%) |
Other | 89 (7.1%) |
Haematological | 141 (11.2%) |
Non-Hodgkin's lymphoma | 75 (6.0%) |
Hodgkin's disease | 13 (1.0%) |
Leukaemia | 28 (2.2%) |
Multiple myeloma | 22 (1.8%) |
Other | 5 (0.4%) |
Extent (solid tumours only) | |
Locoregional | 893 (80.0%) |
Metastatic | 223 (20.0%) |
Cancer status | |
Newly diagnosed/remission | 888 (70.6%) |
Recurrence/progression | 369 (29.4%) |
Performance status | |
0–1 | 900 (71.6%) |
2–3 | 112 (8.9%) |
4 | 245 (19.5%) |
Neutropenia | 49 (3.9%) |
Treatments prior to ICU admission (past 6 months) | |
Chemotherapy | 273 (21.7%) |
Radiation therapy | 314 (25.0%) |
Surgery | 814 (64.8%) |